DEADLINE ALERT for ONTF, SNAP, NVAX, Z/ZG: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
November 23, 2021 12:00 ET
|
Law Offices of Howard G. Smith
BENSALEM, Pa., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
NOVAVAX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Novavax, Inc. and Encourages Investors to Contact the Firm
November 22, 2021 22:30 ET
|
Bragar Eagel & Squire
NEW YORK, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against...
Dyadic’s C1 Production Platform Utilized in ZAPI Study Published in “VACCINES” a Leading Peer-Reviewed Scientific Journal
June 28, 2021 08:30 ET
|
Dyadic International, Inc.
Dyadic’s C1-cell protein production platform selected as a fast response vaccine manufacturing model against zoonotic diseases.C1 -cell platform expressed SBV antigen exhibited efficacy, potency, and...
Novavax and Catalent Announce Closing of Strategic Partnership
July 31, 2019 16:30 ET
|
Novavax, Inc.; Catalent Biologics
GAITHERSBURG, Md., July 31, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and...